Product Manual

Solana SARS-CoV-2 Assay Page 10 of 13
Homology Results of Solana® SARS-COV-2 Primers Against Cross-Reactants
Organism
# Sequences ≥80% Conserved to both Primers
Influenza B Virus
0
Influenza C Virus
0
Human Metapneumovirus
0
Human Parainfluenza Virus 1-4
0
Human Parechovirus
0
Human Respiratory Syncytial Virus
0
Rhinovirus
0
SARS-1
227
Bacillus anthracis
0
Candida albicans
0
Chlamydia pneumoniae
0
Chlamydia psittaci
0
Corynebacterium diphtheriae
0
Coxiella burnetii
0
Haemophilus influenzae
0
Legionella
0
Leptospira
0
Moraxella catarrhalis
0
Mycobacterium tuberculosis
0
Mycoplasma pneumoniae
0
Neisseria elongata & N. meningitidis
0
Pneumocystis jirovecii
0
Pseudomonas aeruginosa
0
Staphylococcus aureus
0
Staphylococcus epidermidis
0
Streptococcus pneumoniae
0
Streptococcus pyogenes
0
Streptococcus salivarius
0
INTERFERENCE SUBSTANCES STUDIES
A study was performed to demonstrate that potentially interfering substances that may be found in the upper respiratory
tract do not cross-react or interfere with the detection of SARS-CoV-2 in the Solana SARS-CoV-2 Assay. Fourteen (14)
potential interfering substances in the concentrations listed below were tested in the absence or presence of SARS-CoV-2.
None of these substances demonstrated cross-reactivity or interference.
Cross-Reactivity/Interference Results
Interfering Substance Active Ingredient Concentration
Cross-Reactivity
Results*
Interference
Results*
Afrin – nasal spray
Oxymetazoline
5%
No Cross-Reactivity
No Interference
Blood (human)
Blood
5%
No Cross-Reactivity
No Interference
Chloraseptic, Cepacol
Benzocaine, Menthol
0.7 g/mL
No Cross-Reactivity
No Interference
Flonase
Fluticasone
5%
No Cross-Reactivity
No Interference
Halls Relief Cherry Flavor
Menthol
0.8 g/mL
No Cross-Reactivity
No Interference
Nasocort Allergy 24 hour
Triamcinolone
5%
No Cross-Reactivity
No Interference